• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,503.60 -1,677.12
( -2.15%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
67,213.51 -1,043.45
(-1.53%)
Nikkei 225
10,469.05 -196.83
(-1.85%)
Forex
USD-INR
95.36 0.17
(0.18%)
EUR-INR
108.98 0.13
(0.12%)
GBP-INR
127.38 0.36
(0.28%)
JPY-INR
0.59 0.00
(-0.24%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
108.9247686
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
55.3
5425.31
EPS(TTM)
Face Value()
Div & Yield %
9.25
1
0.1
 

sylph technologies ltd
Marksans Pharma consolidated net profit rises 63.59% in the March 2026 quarter
May 26,2026
Net profit of Marksans Pharma rose 63.59% to Rs 148.13 crore in the quarter ended March 2026 as against Rs 90.55 crore during the previous quarter ended March 2025. Sales rose 20.84% to Rs 856.11 crore in the quarter ended March 2026 as against Rs 708.46 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.81% to Rs 417.90 crore in the year ended March 2026 as against Rs 380.58 crore during the previous year ended March 2025. Sales rose 12.51% to Rs 2950.94 crore in the year ended March 2026 as against Rs 2622.85 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales856.11708.46 21 2950.942622.85 13
OPM %22.8317.92 -20.3620.31 -
PBDT224.29138.84 62 659.19587.35 12
PBT200.00116.09 72 560.56503.97 11
NP148.1390.55 64 417.90380.58 10